Compare · ICUI vs MDLN
ICUI vs MDLN
Side-by-side comparison of ICU Medical Inc. (ICUI) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ICUI and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $52.27B, about 13.3x ICUI ($3.94B).
- MDLN has hit the wire 4 times in the past 4 weeks while ICUI has been quiet.
- MDLN has more recent analyst coverage (25 ratings vs 15 for ICUI).
- Company
- ICU Medical Inc.
- Medline Inc.
- Price
- -
- -
- Market cap
- $3.94B
- $52.27B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 1992
- 2025
- News (4w)
- 0
- 4
- Recent ratings
- 15
- 25
ICU Medical Inc.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation, such as sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; IV mediation safety software, including ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; and related professional services. Further, it provides critical care products comprising Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Latest ICUI
- BTIG Research initiated coverage on ICU Medical with a new price target
- SEC Form SD filed by ICU Medical Inc.
- ICU Medical upgraded by Needham with a new price target
- President Woolson Daniel sold $280,685 worth of shares (2,123 units at $132.21), decreasing direct ownership by 9% to 22,479 units (SEC Form 4)
- ICU Medical Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- VP, General Counsel Sanzone Virginia Ruth sold $303,624 worth of shares (2,447 units at $124.08), decreasing direct ownership by 11% to 19,460 units (SEC Form 4)
- Director Kennedy Kolleen T converted options into 1,254 shares, increasing direct ownership by 38% to 4,539 units (SEC Form 4)
- Director Hernandez Laurie converted options into 1,254 shares, increasing direct ownership by 35% to 4,862 units (SEC Form 4)
- Director Finney Elisha W converted options into 1,254 shares, increasing direct ownership by 31% to 5,249 units (SEC Form 4)
- Director Abbey Donald converted options into 1,254 shares, increasing direct ownership by 26% to 6,004 units (SEC Form 4)
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Leadership Update
- Medline announces Prime Vendor agreement with Allina Health
- Securing new 1.6-plus million square feet of new space after fire, Medline leases two large distribution centers in Northern California
- Medline to report second quarter 2026 results on August 5, 2026
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Financial Officer Drazin Michael B covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)